Brief: Gossamer Bio - Board Approves Amendment And Restatement Of Bylaws Effective Sept 3, 2026 - SEC Filing
03/09/2026 22:38
BRIEF-Gossamer Bio - Board Approves Amendment And Restatement Of Bylaws Effective Sept 3, 2026 - SEC Filing Sept 3 (Reuters) - Gossamer Bio, Inc. GOSS.O:
GOSSAMER BIO - BOARD APPROVES AMENDMENT AND RESTATEMENT OF BYLAWS EFFECTIVE SEPT 3, 2026 - SEC FILING
Source text: []
Further company coverage: GOSS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Gossamer Bio
See all newsBrief: Gossamer Bio Submits New Drug Application To US FDA For Seralutinib For The Treatment Of Pulmonary Arterial Hypertension
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM
Brief: Gossamer Bio - Board Approves Amendment And Restatement Of Bylaws Effective Sept 3, 2026 - SEC Filing